Court Dismisses Trade Secret Claims Against VillageMD

A Michigan court ruled that plaintiffs failed to prove the existence of trade secrets or protect them under state law.

Updated on Oct. 27, 2026 in Business Strategy

Isometric editorial illustration of stacked stone arches and rectilinear blocks in muted tones, representing the structure of a legal ruling. — A Michigan court dismissed trade secret misappropriation claims against VillageMD, ruling that plaintiffs failed to prove the existence of protected trade secrets. AI Illustration. Upload story photo >

A Michigan court granted summary disposition in favor of VillageMD and Envision defendants regarding claims of trade secret misappropriation and breach of contract. The ruling centered on a failure to demonstrate the Screening Guide qualified as a protected trade secret.

Why it matters

The decision clarifies the high threshold for trade secret protection in Michigan by emphasizing the legal necessity of proving both independent economic value and consistent efforts to maintain secrecy.

The ruling applied the statutory framework of MCL 445.1902(d) for trade secret qualification and MCL 445.1902(ii) regarding mandatory secrecy efforts. These benchmarks served as the definitive criteria for the court to dismiss the misappropriation claims.

The players

VillageMD

A healthcare provider network that was named as a defendant in the trade secret misappropriation and breach of contract lawsuit.

Envision

An organization named as a co-defendant alongside VillageMD in the legal proceedings regarding alleged trade secret violations.

The details

The court found that the plaintiffs could not identify trade secrets with the required specificity or show that their Screening Guide held independent economic value. Furthermore, the court determined there was no evidence that the plaintiffs took reasonable steps to keep the information secret.

October 27, 2026: The ruling was formally issued.

Market Landscape

This litigation highlights the high stakes of intellectual property disputes in the healthcare sector, where proprietary tools are often central to competitive strategies. The court's decision signals a broader trend where companies must rigorously document and protect internal processes to maintain trade secret status in a legal environment.

For business owners and stakeholders, this ruling serves as a warning that internal guides or operational processes are not automatically legally protected without explicit security measures. Companies must ensure their confidentiality protocols align with state statutory requirements to prevent the loss of competitive advantages in court.

The takeaway

Organizations should perform regular audits of their internal documents to ensure that materials intended to be proprietary meet the legal definition of trade secrets. Implementing and documenting strict access controls remains the primary way to safeguard intellectual property during litigation.